But that being said, the biotech space is always one that, uh, is a good investable thesis in terms of outcomes, not just for covid, but for other terminal illnesses and hard to treat diseases.
但話說回來,生物技術領域始終是一個,呃,從結果來看是一個很好的可投資的論文,不僅僅是科維德,還有其他的絕症和難治疾病。